An organic amino compound in which an aminoalkyl group is linked to an arene.
ChEBI ID: 64365
Member | Definition | Role |
---|---|---|
2-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the 2 position on the ring. | 2-methylhistamine |
4-methoxybenzylamine | An aralkylamino compound that is benzylamine substituted by a methoxy group at the para position. | 1-(4-methoxyphenyl)methanamine |
4-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the 5 position on the ring. | 4-methylhistamine |
alpha-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position. | alpha-methylhistamine |
alpha-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position (the R-enantiomer). | (R)-alpha-methylhistamine |
histamine | A member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group. | histamine |
metaproterenol | A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself. | 5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol; metaproterenol |
porphobilinogen | A dicarboxylic acid that is pyrole bearing aminomethyl, carboxymethyl and 2-carboxyethyl substituents at positions 2, 3 and 4 respectively. | porphobilinogen |
tryptamine | An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position. | tryptamine |
vanillylamine | vanillylamine |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 23,516 (60.83) | 18.7374 |
1990's | 6,559 (16.97) | 18.2507 |
2000's | 4,248 (10.99) | 29.6817 |
2010's | 3,246 (8.40) | 24.3611 |
2020's | 1,089 (2.82) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1,694 (4.07%) | 5.53% |
Reviews | 2,180 (5.24%) | 6.00% |
Case Studies | 562 (1.35%) | 4.05% |
Observational | 19 (0.05%) | 0.25% |
Other | 37,133 (89.29%) | 84.16% |